Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation
NCT ID: NCT02844959
Last Updated: 2016-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2016-07-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After ablation each patient will be monitored with ECG telemonitoring system for 7 days.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
NCT05961865
Inflammation, Fibrosis and Risk of Recurrence After Atrial Fibrillation Ablation
NCT03757741
Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
NCT04342312
Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial Fibrillation
NCT02529319
FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation
NCT06260670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* criteria for ablation of atrial fibrillation.
Exclusion Criteria
* ablation other than pulmonary veins isolation during the procedure;
* atrial fibrillation at the beginning of ablation procedure;
* usage of 'single shot' devices.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcin Grabowski
Clinical Professor, Marcin Grabowski, Medical University of Warsaw
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcin D Grabowski, PhD
Role: STUDY_CHAIR
1st Department of Cardiology Medical University of Warsaw
Paweł Balsam, PhD
Role: STUDY_CHAIR
1st Department of Cardiology Medical University of Warsaw
Piotr Lodziński, PhD
Role: STUDY_CHAIR
1st Department of Cardiology Medical University of Warsaw
Grzegorz Opolski, Professor
Role: STUDY_CHAIR
1st Department of Cardiology Medical University of Warsaw
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
1st Department of Cariology of Medcial University of Warsaw
Warsaw, Masovian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KB/143/2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.